Remove tag health-insurance
article thumbnail

Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD)

Rethinking Clinical Trials

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health.

article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

This may be the only interaction the family has with a healthcare professional, so if there are needs around behavior, health, social needs they will be addressed during these visits. Based on these findings, the research team initiated a larger PARENT trial that had 3 parent coaches at federally qualified health centers.

Trials 271
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

American health is in for a “world of hurt”

World of DTC Marketing

has also seen reversals in health improvements since 2010, partly due to increasing rates of obesity, high blood pressure, and high blood sugar. . Obesity, lack of exercise, and too much salt are all contributing to a myriad of health issues that are going to drive up healthcare costs. and $20 billion in health-care costs.

article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. Then, against the advisory panel’s advice, Aduhelm was approved, but insiders within the industry criticized both the FDA and Biogen weren’t sold on the drug or its price tag. Biogen is in trouble.

Drugs 222
article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

Fleurence, PhD, MSc Senior Advisor National Institutes of Health Joshua M. There is high cost of treatment and insurance prior-authorization requirements.       Speakers Rachael L. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. Rates are the highest among 20-39-year-olds.

article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

Chan School of Public Health, says, “at the moment, people are skeptical enough of the pharmaceutical industry that they’re going to have a tough time saying that if the government gets you a discount, you won’t get discoveries.”. All this means is that America’s health care costs will continue to climb to record levels.

Drugs 222
article thumbnail

Healthcare doesn’t give a damn about patients

World of DTC Marketing

Health insurers in individual marketplaces across 13 states and Washington D.C. Pfizer, for instance, hiked the cost of its leukemia medication Besponsa again this month, bringing its per-vial price tag to $21,056. have raised drug prices 1,186 times so far this year. But they’re not alone.

Packaging 183